Minerva Neurosciences to Present at Jefferies 2016 London Healthcare Conference on November 17, 2016
(Thomson Reuters ONE) -
WALTHAM, Mass., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc.
(NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the
development of therapies to treat central nervous system (CNS) disorders, today
announced that it will present at the Jefferies 2016 London Healthcare
Conference on November 17, 2016 at 12:40 p.m. GMT (7:40 a.m. EST).
The presentation will be web cast and accessible through the investor relations
section of the Company's web site, http://ir.minervaneurosciences.com.
About Minerva Neurosciences:
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company
focused on the development and commercialization of a portfolio of products to
treat CNS diseases. Minerva's proprietary compounds include: MIN-101, which has
completed a Phase IIb clinical trial for schizophrenia; MIN-117, which has
completed a Phase IIa clinical trial development for MDD; MIN-202 (JNJ-
42847922), which has completed Phase IIa and Phase Ib clinical trials for
insomnia and MDD, respectively; and MIN-301, in pre-clinical development for
Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global
Market under the symbol "NERV." For more information, please
visit www.minervaneurosciences.com.
Contact:
William B. Boni
VP, Investor Relations/
Corp. Communications
Minerva Neurosciences, Inc.
(617) 600-7376
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Minerva Neurosciences, Inc. via GlobeNewswire
Datum: 10.11.2016 - 14:30 Uhr
Sprache: Deutsch
News-ID 506256
Anzahl Zeichen: 1982
contact information:
Town:
Waltham
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 189 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Minerva Neurosciences to Present at Jefferies 2016 London Healthcare Conference on November 17, 2016"
steht unter der journalistisch-redaktionellen Verantwortung von
Minerva Neurosciences, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
